World News

Eli Lilly's experimental diabetes drug helped patients lose 17% of their body weight

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

Retatrutide reduced body weight by up to 16.8% over 40 weeks in a Phase 3 trial — and unlike Ozempic or Mounjaro, it activates three hormonal pathways at once

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button